Atlas Trials

A New Fast DWI-based MR Protocol for Surveillance in Patients With a High Risk of Ovarian Cancer Recurrence During PARP-inhibitors Maintenance to Enhance Secondary Cytoreduction Results

Clinical trial NCT06541171 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06541171
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Ovarian CancerRecurrent Ovarian Carcinoma
Start date
2024-09-01
Primary completion
2025-08-31
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.